Publications by authors named "Michael Radziewitz"

Claim this Profile
T
Topical Application of the PI3Kβ-Selective Small Molecule Inhibitor TGX-221 Is an Effective Treatment Option for Experimental Epidermolysis Bullosa Acquisita.
Hannah Zillikens, Anika Kasprick, Colin Osterloh, Natalie Gross, Michael Radziewitz

Front Med (Lausanne)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis